,,iv  #aag? ,,congress  #a/ ,session    
,h4 ,,res4 #aaf  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,febru>y #aa1         
#bjba,mr4 ,gro?man submitt$ ! foll[+    
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,en]gy & ,comm]ce  ,,resolution     
,recogniz+ ! b5efits ( vitam9 ,d intake 
= prev5t+ respiratory infection &       
,,covid-#ai complications1 & to enc\rage
 ! ,c5t]s = ,disease ,control &         
,prev5tion & ! ,food & ,drug            
,adm9i/ration to issue guidance on      
vitam9 ,d intake = eld]ly &             
immunocompromis$ individuals dur+ !     
coronavirus p&emic4  ,:]eas1 9 ,decemb] 
#bjbj1 #abj heal?1 sci5ce1 & m$ical     
exp]ts f ! ,unit$ ,k+dom1 ! ,unit$      
,/ates1 & ,europe s5t an op5 lett] to _w
 gov]nm5ts ass]t+ t !re is cle>         
sci5tific evid5ce t vitam9 ,d r$uces    
,,covid-#ai infections1                 
hospitalizations1 & dea?s2 ,:]eas1 9    
,july #bjbj1 ! ,am]ican ,society = ,bone
 & ,m9]al ,rese>* 7,,asbmr71 ! ,am]ican 
,association ( ,cl9ical ,endocr9ologi/s 

7,,aace71 ! ,endocr9e ,society1 !       
,european ,calcifi$ ,tissue ,society1 ! 
,national ,o/eoporosis ,f\ndation       
7,,n(71 & ! ,int]national ,o/eoporosis  
,f\ndation 7,,i(7 issu$ jo9t guidance on
 vitam9 ,d intake dur+ ! ,,covid-#ai    
p&emic2 ,:]eas ov] #dj p]c5t ( ,am]ican 
adults are vitam9 ,d defici5t &         
defici5cy rates )9 ,african-,am]ican &  
,lat9o populations range f #gj to #hj   
p]c5t2 ,:]eas1 9 ,septemb] #bjbj1 ,unit$
 ,/ates infecti\s disease exp]t ,dr4    
,an?ony ,fauci publicly comm5t$ on !    
importance ( vitam9 ,d = immune heal? & 
vitam9 ,d defici5cies result+ 9 increas$
 susceptibility to infection2 ,:]eas !  
,unit$ ,k+dom ,national ,heal? ,s]vice  
has a program to di/ribute vitam9 ,d    
supplem5ts to ov] #b4e million at-risk  
individuals1 includ+ s5iors1 individuals
 9 long-t]m c>e facilities1 &           
individuals ) preexi/+ heal? conditions1
 dur+ ! ,,covid-#ai p&emic2 ,:]eas      
,scotl&1 ,wales1 & ,nor!rn ,irel&'s     
public heal? ag5cies issu$ guidance     

enc\rag+ vitam9 ,d intake ?r\gh\t !     
,,covid-#ai p&emic2 ,:]eas sev]al /udies
 conduct$ by m$ical rese>* teams &      
,unit$ ,/ates m$ical in/itutions h      
demon/rat$ a correlation betwe5 vitam9  
,d defici5cies & poor ,,covid-#ai pati5t
 outcomes1 includ+ /udies by ,nor?we/]n 
,univ]sity & ! ,univ]sity ( ,*icago     
,m$ic9e2 ,:]eas ,h>v>d ,univ]sity's     
,t4,h4 ,*an ,s*ool ( ,public ,heal? is  
organiz+ a cl9ical trial ( #b1gjj       
p>ticipants to exam9e ! relation%ip     
betwe5 vitam9 ,d & ,,covid-#ai outcomes2
 & ,:]eas !re are ov] #cj active cl9ical
 trials & #ac complet$ cl9ical trials   
worldwide exam9+ ! correlation betwe5   
,,covid-#ai infection & vitam9 ,d3 ,n[1 
!re=e1 be x ,t ! ,h\se (                
,repres5tatives-- 7#a7 recognizes !     
b5efits ( vitam9 ,d intake aga9/ prev5t+
 respiratory complications & infection2 
7#b7 recognizes ! b5efits ( vitam9 ,d   
intake = improv$ immune heal? &         
response2  7#c7 recognizes ! correlation
 betwe5 vitam9 ,d defici5cies & poor    

,,covid-#ai pati5t outcomes1 includ+    
hospital /ays1 ,,icu admittance1 &      
mortality2 &  7#d7 enc\rages ! ,c5t]s = 
,disease ,control & ,prev5tion & ! ,food
 & ,drug ,adm9i/ration to update exi/+  
guidance & issue new guidance on vitam9 
,d intake dur+ ! ,,covid-#ai p&emic4